Oneness Biotech Co., Ltd. (TPEX: 4743)
Taiwan
· Delayed Price · Currency is TWD
86.30
-1.00 (-1.15%)
Jan 2, 2025, 12:28 PM CST
Oneness Biotech Revenue
Oneness Biotech had revenue of 29.30M TWD in the quarter ending September 30, 2024, with 53.97% growth. This brings the company's revenue in the last twelve months to 112.20M, up 47.85% year-over-year. In the year 2023, Oneness Biotech had annual revenue of 86.78M, down -91.86%.
Revenue (ttm)
112.20M
Revenue Growth
+47.85%
P/S Ratio
n/a
Revenue / Employee
2.61M
Employees
43
Market Cap
40.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
Dec 31, 2019 | 13.48M | -5.38M | -28.54% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |
Pegavision | 7.06B |